机译:开放式标签,多期,剂量升级的第二期临床试验坦德林Alfa(IL-18BP)在成人发作仍然疾病中的安全性和有效性
Univ Hosp Geneva Div Rheumatol Dept Internal Med Specialties CH-1205 Geneva Switzerland;
UPMC Pierre Louis Inst Epidemiol &
Publ Hlth GRC 08 Paris France;
Univ Klinikum Erlangen Dept Internal Med Rheumatol &
Immunol 3 Erlangen Germany;
CHU Vaudois Div Immunol &
Allergy Lausanne Switzerland;
Humboldt Univ Freie Univ Berlin Charite Univ Med Berlin Berlin Germany;
Asklepios Klinikum Dept Internal Med Rheumatol Nephrol &
Immunol Hamburg Germany;
Univ Lille Dept Internal Med Lille France;
Univ Montpellier Dept Rheumatol Montpellier France;
CHU Bordeaux FHU Acronim Dept Rheumatol Bordeaux France;
CHU Nantes Dept Internal Med Nantes France;
CHU Strasbourg Dept Clin Immunol &
Internal Med Strasbourg France;
Medius Klin Kirchheim Dept Internal Med Rheumatol &
Immunol Kirchheim Unter Teck Germany;
Univ Lubeck Dept Rheumatol &
Clin Immunol Lubeck Germany;
Ludwig Maximilians Univ Munchen Div Rheumatol &
Clin Immunol Dept Internal Med 4 Munich Germany;
Univ Hosp Geneva Div Rheumatol Dept Internal Med Specialties CH-1205 Geneva Switzerland;
AB2 Bio Ltd EPFL Innovat Pk Lausanne Switzerland;
AB2 Bio Ltd EPFL Innovat Pk Lausanne Switzerland;
adult onset still's disease; inflammation; juvenile idiopathic arthritis;
机译:开放式标签,多期,剂量升级的第二期临床试验坦德林Alfa(IL-18BP)在成人发作仍然疾病中的安全性和有效性
机译:Gemtuzumab ozogamicin治疗
机译:<4?年的PKU患者中沙丙蝶呤的功效,安全性和群体药代动力学:SPARK开放标签,多中心,随机IIIb期试验的结果
机译:结合临床试验阶段II和III的统计方法
机译:充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性:一项多中心,对照,开放标签的临床试验
机译:扩展报告:关于tadekinig alfa(IL-18BP)在成年性Still病中的安全性和有效性的开放式多中心剂量递增的II期临床试验
机译:急性心肌梗死患者吗啡与甲氧基氟丙烷的镇痛疗效和安全性:Anemon-sirio的理由和设计3研究:多期,开放标签,II期,随机临床试验